Making medicines affordable for everyone across America

Our Call to Action

Leading biopharma Innovators, investors, and patient groups urged congress to solve affordability for patients through insurance reform. More than 300 industry leaders share ideas on how to save all Americans money while preserving research and development. Caution that government price controls will cease biopharma investment and significantly reduce availability of new medicines. Read what more here.

Our Call to Action
More than 400 biopharma innovators, investors, and patient advocates urge Congress to solve affordability for patients through insurance reforms. The letter shares ideas on how to save all Americans money while preserving research and development. It cautions that government price controls will cease biopharma investment and significantly reduce availability of new medicines.
Read the letter here.
Our Videos & Animation
Explore NPLB's core principles, positions and plans to make medicines affordable for all Americans, encourage innovation, and ensure that patients are heard.

What we're tweeting (and retweeting)

Follow us @NPLB_org
Follow us @NPLB_org

What we're tweeting (and retweeting)

Our goals

Make sure that everyone in America has affordable healthcare they can actually use and guarantee that our country continues to invest in new medicines that will help patients now and in the future.

Eliminate
out-of-pocket costs

Expand insurance
to everyone

Ensure that all drugs go generic

We're determined to help you get the care and medicines your doctors say you need.

We are dedicated to creating and maintaining patient access to affordable drugs by holding both insurance and pharmaceutical companies accountable for their policies and practices.

About us
Lynda Gorov
Executive Editor

We are championing new laws to get insurance companies to do away with copays and out-of-pocket expenses.

We are pushing for reforms to guarantee that drug companies let their drugs go generic when they're supposed to do so.

Letter from the executive editor
All articles
All posts

The Right Prescription for Affordable Drugs

Time for Congress to enact reforms that cap Medicare Part D beneficiaries out-of-pocket costs.

Congress is about to legislate a future without new medicines. We have a better plan.

Cutting investment into new medicines turns out to be no way to save.

BIOCENTURY: Investors, biopharma companies sound alarms on drug pricing legislation

"small biotechs that rely on venture capital...will disappear."

Lawmakers Urged to Support Biopharma Innovation and Affordability

Pass reforms to lower out-of-pocket costs. Caution! Price controls could cease biopharma investment

BIOCENTURY: Congress relying on flawed model to set drug pricing policy

CBO MODEL IGNORES IMPACT ON PRECLINICAL BIOTECHS

NPLB Gets Animated: Roadmap to Patient Affordability and Innovation

Animation: Insurance Reform Needed to Cover Prescribed Medicines at Low Cost

Explore our cause

Help for patients

Don’t despair. There’s help for you: assistance with copays, deductibles and other expenses.

Our strategy

Coalition building. Raising awareness. Encouraging innovation. Changing perceptions and policy. Making medicines affordable.

Our presentations

Clear-cut ideas and solutions. The science, economics and policy of affordability and innovation.

Did you know?

Increasing out-of-pocket costs by just $10 per prescription causes a 33% rise in mortality because fewer patients take the drugs their doctors prescribe.

Source: National Bureau of Economic Research, https://www.nber.org/papers/w28439Get involved